Sun Pharma’s arm gets US FDA’s approval for diclofenac sodium topical solution: Report

09 Feb 2017 Evaluate

Taro Pharmaceutical Industries, the US subsidiary of Sun Pharmaceuticals Industries, has reportedly received tentative approval from the US Food and Drug Administration (US FDA) for diclofenac sodium topical solution of 2 per cent strength. Diclofenac sodium is indicated for mild to moderate pain, or signs and symptoms of osteoarthritis or rheumatoid arthritis.

Sun Pharmaceutical Industries is an Indian multinational pharmaceutical company that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) primarily in India and the United States.

Sun Pharma Inds. Share Price

1589.30 -20.85 (-1.29%)
29-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1589.30
Dr. Reddys Lab 1208.45
Cipla 1320.35
Zydus Lifesciences 890.20
Lupin 2131.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×